The on-going search for clinical trials suitable for patients with aggressive melanoma

Description: James Larkin, MD, PhD, of the Royal Marsden NHS Foundation Trust, London, UK, discusses aggressive melanoma, which he considers to be one of the key areas in the field.
One of the problems that patients have come across with trials is that it usually takes 2-3 weeks to start the program since patients require up-to-date scans etc. However, Dr Larkin points out, such patients cannot wait this long to start treatments, but in order to collect sufficient data to advance the study, the reality is that it is unlikely for every patient to go onto a clinical trial.
Recorded at the American Society of Oncology (ASCO) 2016 Annual Meeting held in Chicago, IL.